Phase II Trial of Temozolomide and Irinotecan as Second-Line Treatment for Advanced Non–small Cell Lung Cancer
2006 ◽
Vol 1
(3)
◽
pp. 245-251
◽
Nicholas W. Choong
◽
Ann M. Mauer
◽
Philip C. Hoffman
◽
Charles M. Rudin
◽
Jerome D. Winegarden
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7316-7316
M. B. Kleinman
◽
I. Stewart
◽
S. Ratmanskiy
◽
M. Gayle
◽
P. Bonomi
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7263-7263
C. Kouroussis
◽
K. Syrigos
◽
A. Potamianou
◽
N. Ziras
◽
P. Ziotopoulos
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7316-7316
M. B. Kleinman
◽
I. Stewart
◽
S. Ratmanskiy
◽
M. Gayle
◽
P. Bonomi
2008 ◽
Vol 26
(15_suppl)
◽
pp. 19033-19033
◽
M. Joppert
◽
M. Knapp
◽
S. R. Dakhil
◽
R. V. Boccia
◽
R. Steis
◽
...
2009 ◽
Vol 21
(1)
◽
pp. 86-90
◽
A. Ravaioli
◽
M. Papi
◽
E. Pasquini
◽
M. Marangolo
◽
B. Rudnas
◽
...
G. Numico
◽
L. Buffoni
◽
V. Dongiovanni
◽
M. Schena
◽
C. Fissore
◽
...
Alberto Ravaioli
◽
Manuela Fantini
◽
Fabrizio Drudi
◽
Maximilian Papi
◽
Enzo Pasquini
◽
...
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7263-7263
C. Kouroussis
◽
K. Syrigos
◽
A. Potamianou
◽
N. Ziras
◽
P. Ziotopoulos
◽
...
2003 ◽
Vol 41
◽
pp. S237
◽
F. Anthony Greco
◽
Howard A. Burris
◽
Denise Aysel Yardley
◽
John Daniel Hainsworth
2021 ◽
Vol 16
(3)
◽
pp. S501
P. Deng
◽
H. Yang
◽
C. Chen
◽
C. Hu
◽
L. Cao
◽
...